Cite
HARVARD Citation
Foley, R. et al. (n.d.). European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi‐institutional study. BJU international. pp. 706-713. [Online].